Modulation of the ceramide level, a novel therapeutic concept
The sphingomyelin (SM) pathway is an ubiquitous and evolutionarily conserved signaling system in which ceramide (CA), generated from SM by the action of various isoforms of sphingomyelinases (SMases) functions as an important second messenger. Recent evidence suggests that branching pathways of sphi...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
1 September 2000
|
| In: |
Current drug targets
Year: 2000, Jahrgang: 1, Heft: 2, Pages: 185-205 |
| ISSN: | 1873-5592 |
| DOI: | 10.2174/1389450003349272 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.2174/1389450003349272
|
| Verfasserangaben: | R. Claus, S. Russwurm, M. Meisner, R. Kinscherf, and H.P. Deigner |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1563460203 | ||
| 003 | DE-627 | ||
| 005 | 20230427122056.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170913s2000 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1389450003349272 |2 doi | |
| 035 | |a (DE-627)1563460203 | ||
| 035 | |a (DE-576)493460209 | ||
| 035 | |a (DE-599)BSZ493460209 | ||
| 035 | |a (OCoLC)1340979144 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Claus, Ralf |d 1967- |e VerfasserIn |0 (DE-588)122036441 |0 (DE-627)705746828 |0 (DE-576)293060630 |4 aut | |
| 245 | 1 | 0 | |a Modulation of the ceramide level, a novel therapeutic concept |c R. Claus, S. Russwurm, M. Meisner, R. Kinscherf, and H.P. Deigner |
| 264 | 1 | |c 1 September 2000 | |
| 300 | |a 21 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 13.09.2017 | ||
| 520 | |a The sphingomyelin (SM) pathway is an ubiquitous and evolutionarily conserved signaling system in which ceramide (CA), generated from SM by the action of various isoforms of sphingomyelinases (SMases) functions as an important second messenger. Recent evidence suggests that branching pathways of sphingolipid metabolism mediate either apoptotic or mitogenic responses depending on cell type and the nature of the stimulus. Events involving SM metabolites and CA in particular include proliferation differentiation and growth arrest as well as the induction of apoptosis. An improved understanding of SMase-dependent signaling may afford relevant insights into the pathogenesis of diseases and provide novel strategies and selective targets for a therapeutic intervention e.g. in cancer, cardiovascular and neurodegenerative diseases, HIV and septic shock. This article briefly summarizes the role of SMases in signaling pathways, its potential contribution in the development and maintenance of various pathobiological states and analyzes the perspective of a potentially isotype-specifc inhibition of S Mases as a novel therapeutic | ||
| 650 | 4 | |a Ceramide CA | |
| 650 | 4 | |a Enzyme | |
| 650 | 4 | |a HIV Infection | |
| 650 | 4 | |a Metabolic | |
| 650 | 4 | |a Metabolites | |
| 650 | 4 | |a September 2000 | |
| 650 | 4 | |a Sphinomyelin | |
| 650 | 4 | |a TGF | |
| 700 | 1 | |a Russwurm, Stefan |d 1967- |e VerfasserIn |0 (DE-588)114532109 |0 (DE-627)389522619 |0 (DE-576)28980020X |4 aut | |
| 700 | 1 | |a Meisner, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kinscherf, Ralf |e VerfasserIn |0 (DE-588)1084823748 |0 (DE-627)848747925 |0 (DE-576)169729516 |4 aut | |
| 700 | 1 | |a Deigner, Hans-Peter |d 1958- |e VerfasserIn |0 (DE-588)1012570606 |0 (DE-627)699716705 |0 (DE-576)345618505 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current drug targets |d Hilversum : Bentham Science Publ., 2000 |g 1(2000), 2, Seite 185-205 |h Online-Ressource |w (DE-627)327962399 |w (DE-600)2044606-8 |w (DE-576)273880896 |x 1873-5592 |7 nnas |a Modulation of the ceramide level, a novel therapeutic concept |
| 773 | 1 | 8 | |g volume:1 |g year:2000 |g number:2 |g pages:185-205 |g extent:21 |a Modulation of the ceramide level, a novel therapeutic concept |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1389450003349272 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20170913 | ||
| 993 | |a Article | ||
| 994 | |a 2000 | ||
| 998 | |g 1012570606 |a Deigner, Hans-Peter |m 1012570606:Deigner, Hans-Peter |d 160000 |d 160100 |e 160000PD1012570606 |e 160100PD1012570606 |k 0/160000/ |k 1/160000/160100/ |p 5 |y j | ||
| 998 | |g 1084823748 |a Kinscherf, Ralf |m 1084823748:Kinscherf, Ralf |d 50000 |d 53100 |e 50000PK1084823748 |e 53100PK1084823748 |k 0/50000/ |k 1/50000/53100/ |p 4 | ||
| 998 | |g 122036441 |a Claus, Ralf |m 122036441:Claus, Ralf |d 160000 |d 160100 |e 160000PC122036441 |e 160100PC122036441 |k 0/160000/ |k 1/160000/160100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1563460203 |e 2980121649 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"id":{"issn":["1873-5592"],"eki":["327962399"],"zdb":["2044606-8"]},"origin":[{"dateIssuedKey":"2000","publisher":"Bentham Science Publ.","dateIssuedDisp":"2000-","publisherPlace":"Hilversum"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"the international journal for timely in-depth reviews on drug targets","title":"Current drug targets","title_sort":"Current drug targets"}],"part":{"year":"2000","issue":"2","pages":"185-205","volume":"1","text":"1(2000), 2, Seite 185-205","extent":"21"},"pubHistory":["1.2000 -"],"language":["eng"],"recId":"327962399","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 25.09.2017"],"disp":"Modulation of the ceramide level, a novel therapeutic conceptCurrent drug targets"}],"physDesc":[{"extent":"21 S."}],"name":{"displayForm":["R. Claus, S. Russwurm, M. Meisner, R. Kinscherf, and H.P. Deigner"]},"id":{"doi":["10.2174/1389450003349272"],"eki":["1563460203"]},"origin":[{"dateIssuedDisp":"1 September 2000","dateIssuedKey":"2000"}],"language":["eng"],"recId":"1563460203","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 13.09.2017"],"person":[{"display":"Claus, Ralf","roleDisplay":"VerfasserIn","role":"aut","family":"Claus","given":"Ralf"},{"given":"Stefan","family":"Russwurm","role":"aut","roleDisplay":"VerfasserIn","display":"Russwurm, Stefan"},{"given":"M.","family":"Meisner","role":"aut","display":"Meisner, M.","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Kinscherf, Ralf","roleDisplay":"VerfasserIn","given":"Ralf","family":"Kinscherf"},{"role":"aut","display":"Deigner, Hans-Peter","roleDisplay":"VerfasserIn","given":"Hans-Peter","family":"Deigner"}],"title":[{"title_sort":"Modulation of the ceramide level, a novel therapeutic concept","title":"Modulation of the ceramide level, a novel therapeutic concept"}]} | ||
| SRT | |a CLAUSRALFRMODULATION1200 | ||